Benefits
Supports antioxidant enzyme defense
Manganese is the required cofactor for manganese superoxide dismutase (MnSOD/SOD2), the primary antioxidant enzyme inside mitochondria. Adequate manganese status helps maintain the body's defense against superoxide radicals generated during normal energy metabolism.
Helps maintain healthy bones
Manganese supports the glycosyltransferase enzymes that build the glycosaminoglycan and proteoglycan framework of bone and connective tissue. Adequate manganese intake helps maintain normal bone formation and skeletal integrity as part of a balanced micronutrient intake.
Supports normal metabolism
As a cofactor for pyruvate carboxylase and other metabolic enzymes, manganese contributes to normal carbohydrate, amino acid, and energy metabolism. Maintaining adequate manganese status supports the enzymatic machinery the body uses to process macronutrients.
Gentle, well-tolerated trace-mineral source
Manganese gluconate is water-soluble and generally mild on the digestive tract, making it a practical way to round out the trace-mineral profile of a multivitamin. It helps ensure intake meets the adequate intake level in people whose diets may fall short.
Mechanism of action
MnSOD cofactor activity
Manganese sits in the active site of mitochondrial superoxide dismutase, where it cycles between oxidation states to convert superoxide radicals into hydrogen peroxide and oxygen. This catalytic role protects mitochondrial proteins, lipids, and DNA from oxidative damage.
Glycosyltransferase activation
Manganese-dependent glycosyltransferases assemble glycosaminoglycan chains onto core proteins to form the proteoglycans that give cartilage and bone matrix their structure. Manganese availability influences the synthesis of these connective-tissue components.
Dissolution and intestinal uptake
The gluconate salt dissolves readily in the gut, releasing Mn2+ ions for absorption across the intestinal mucosa via divalent metal transporters. Overall manganese absorption is low (roughly 3–5%) and is homeostatically regulated by body manganese status.
Clinical trials
Two-year randomized controlled trial of calcium (1000 mg/day) with or without trace minerals (zinc 15 mg, manganese 5 mg, copper 2.5 mg) in older postmenopausal women.
59 postmenopausal women.
Spinal bone mineral density declined in the placebo group but was maintained or slightly increased in women receiving calcium plus trace minerals. CRITICAL CAVEAT: the manganese contribution cannot be isolated from calcium, zinc, and copper, and the trial used a generic trace-mineral mix rather than gluconate specifically. No form-specific trials of manganese gluconate exist.
NIH Office of Dietary Supplements Manganese Health Professional Fact Sheet summarizing the evidence on supplemental manganese absorption and forms.
Evidence review (humans).
The fact sheet states plainly that no data are available on the relative bioavailability of different forms of supplemental manganese, and that overall manganese absorption is low and homeostatically regulated. This means claims that gluconate is better or worse absorbed than other salts are not supported by human evidence.